Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 1774 Neoplasms 1501 Carcinoma, Non-Small-Cell Lung 1043 Prostatic Neoplasms 957 Colorectal Neoplasms 878 Lung Neoplasms 800 Pancreatic Neoplasms 572 Carcinoma, Hepatocellular 542 Leukemia, Myeloid, Acute 541 Stomach Neoplasms 512 Ovarian Neoplasms 507 Neoplasm Metastasis 496 Multiple Myeloma 495 Recurrence 413 Melanoma 386 Squamous Cell Carcinoma of Head and Neck 370 Brain Neoplasms 362 Uterine Cervical Neoplasms 361 Head and Neck Neoplasms 355 Esophageal Neoplasms 312 Precursor Cell Lymphoblastic Leukemia-Lymphoma 310 Lymphoma 305 Endometrial Neoplasms 304 Triple Negative Breast Neoplasms 299 Glioblastoma 298 Rectal Neoplasms 280 Urinary Bladder Neoplasms 264 Sarcoma 264 Hematologic Neoplasms 264 Colonic Neoplasms 254

Interventions

Taxes 1 Specimen Handling 1 Paclitaxel 1 Magnetic Resonance Spectroscopy 1 Gemcitabine 1 Endoscopic Ultrasound-Guided Fine Needle Aspiration 1 Catheter Ablation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Pancreatic Cystic Neoplasm × Clear all

NCT07529483 2026-05-29

ERASE-Chemo

Ohio State University Comprehensive Cancer Center

Phase 2 Recruiting

Gastrointestinal

Pancreatic Cystic Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon ⚡